Showing 9371-9380 of 23022 results for "".
Hepatitis C Treatment: Grim Fiscal Prospects?
https://reachmd.com/programs/gi-insights/hepatitis-c-treatment-grim-fiscal-prospects/2947/We are developing increasingly effective therapies for patients with chronic hepatitis C, yet many physicians who treat a high volume of these patients are struggling to maintain economically viable strategies for providing care. Is treatment of hepatitis C becoming a money-losing proposition? Can aUnveiling the Link Between Dermatological and Cardiovascular Health
https://reachmd.com/programs/clinicians-roundtable/unveiling-the-link-between-dermatological-and-cardiovascular-health/32381/Explore the link between dermatological conditions and cardiovascular health, and discover new diagnostic and treatment possibilities.The Future of IgA Nephropathy: Why Biomarkers Matter
https://reachmd.com/programs/frontlines-iga-nephropathy/the-future-of-iga-nephropathy-why-biomarkers-matter/26942/Dive into the importance of biomarkers in the intensifying pursuit of newer, more effective treatments for IgA nephropathy.Practice Efficiency and Innovation
https://reachmd.com/programs/empower/empower-practice-efficiency-and-innovation/48683/Part five of a five-part business/specialty care optometric series.Overview of the Latest Guidance in IgA Nephropathy Management
https://reachmd.com/programs/kdigo-conversations-nephrology/overview-of-the-latest-guidance-in-iga-nephropathy-management/37115/On this first episode of the KDIGO IgA Nephropathy (IgAN) podcast series, join host Dr. Dana Rizk and special guest Dr. Brad Rovin for a discussion on the latest guidance for managing IgAN. As an expert in glomerular diseases and co-chair of the KDIGO Glomerular Disease Guideline Working Group, Dr.Diagnosing and Treating Immune Checkpoint Inhibitor Colitis Effectively
https://reachmd.com/programs/gi-insights/diagnosing-and-treating-immune-checkpoint-inhibitor-colitis-effectively/32873/Immune checkpoint inhibitor (ICI) colitis comes with unique diagnostic and treatment challenges, which means that recognizing and managing it effectively is key to the best outcomes. Joining Dr. Peter Buch to share her insights on caring for patients with this complex condition is Dr. Yinghong Wang.Early-Stage Prostate Cancer Treatment: Examining Long-Term Complications
https://reachmd.com/programs/frontlines-prostate-cancer/early-stage-prostate-cancer-treatment-examining-long-term-complications/32214/Patients may experience complications from early-stage prostate cancer therapy. Hear clinical data on these risks and their impact on treatment decisions.Diagnosing Muscle Disorders: When to Use Biopsy
https://reachmd.com/programs/neurofrontiers/diagnosing-muscle-disorders-when-to-use-biopsy/26391/Here’s when we should conduct muscle biopsy versus genetic and serological testing to diagnose muscle disorders.Discussing a T2D Medication That Could Reduce Insulin Needs in T1D
https://reachmd.com/programs/diabetes-discourse/discussing-a-t2d-medication-that-could-reduce-insulin-needs-in-t1d/16258/A GLP-1 medication, commonly used to treat type 2 diabetes and obesity, may benefit type 1 diabetes patients.MS in Black and Hispanic Patients: Examining Prevalence and Disease Characteristics
https://reachmd.com/programs/neurofrontiers/ms-in-black-and-hispanic-patients-examining-prevalence-and-disease-characteristics/16268/Explore the CHIMES trial, which looked at the demographics and disease characteristics of Black and Hispanic patients with multiple sclerosis.